Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact.
Breast Cancer Res Treat
; 167(2): 547-554, 2018 01.
Article
in En
| MEDLINE
| ID: mdl-28986743
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Prognosis
/
Breast Neoplasms
/
Receptor, ErbB-2
/
Trastuzumab
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Year:
2018
Type:
Article